Directorsof the Griffin Institute
Alison Rosen is an experienced Chief Executive with over 20 years’ senior leadership experience in the voluntary sector, particularly in social welfare, grant-giving charities and membership organisations. Her experience includes managing organisational change, introducing new and innovative programmes, strategic and business planning, implementing governance frameworks and establishing infrastructure.
As a previous Finance Director and Chartered Accountant, Alison’s skills include financial and resource management, fundraising and business development and an excellent knowledge of charity law. She previously worked for the S&P Sephardi Community for four years, which represents the 350-year-old Jewish Community in the UK, and in that role obtained Heritage Lottery Development Funding for the National Trust site at Bevis Marks synagogue.
Alison is a highly respected, passionate and a driven individual with a strong belief in creativity and innovation and moving an organisation forward to the next stages of development. She is currently guiding The Griffin Institute and NPIMR through its next stages of growth and development, including working on the establishment of a new training centre and expansion of the current research programme.
Professor Nader Francis, MBChB, FRCS, FEBS(hon), PhD
Director of Training
Nader is an expert colorectal surgeon at Yeovil, committed to minimal invasive surgery and enhanced recovery. He is a passionate teacher and educator with an educational PhD in assessment of surgical skills, which underpins his national and international expertise as a trainer and educational lead in the field of laparoscopic colorectal surgery.
Nader Francis has presented widely as speaker, chairman and organiser of educational events and national and international conferences. His educational expertise lies around designing, delivering and assessing educational curricula, including designing objective assessment tools. Over the past 10 years, he has designed and led the delivery of numerous training curricula at both national and international level. He recently served as the National Educational Tutor for Coloproctology for the Association of Coloproctology of Great Britain and Ireland and as the Director of Medical Education at Yeovil District Hospital NHS Foundation Trust.
Nader is currently Chair of the Research Committee of the European Association of Endoscopic Surgery with a research focus on education, colorectal cancer, laparoscopic surgery and perioperative care. He has been chief investigator of a number of studies and has presented and published widely.
Professor Jia Hua, MD, PhD
Director of Science
A qualified medical doctor and trained orthopaedic surgeon in China, Jia Hua completed his PhD in Orthopaedics at the University College London, UK. An expert in the development of endoprosthetic joint replacements, Jia has developed CAD-CAM patient-specific hip implants in collaboration with orthopaedic surgeons at the Royal National Orthopaedic Hospital and other hospitals in UK, and these have been successfully translated into clinical application and directly benefited thousands of osteoarthritis patients.
For many years, Jia has concentrated on regenerative medicine, including research into bone tissue engineering around revision hip implants where osteolysis and aseptic loosening of implants has occurred. He has also used mesenchymal stem cells to enhance the healing of the non-union bone fracture and has carried out research work on rehabilitation engineering, medical images, surgical navigation and robotic-assisted surgery, 3D scaffold and biomaterials, metal 3D-printing, additive manufacture and biomechanics.
Jia has collaborated nationally and internationally with universities, industries and healthcare providers on ground-breaking research, making a significant contribution to scientific knowledge.
Professor Colin Green PhD, DSc(Med), FRCVS, FRC Path, FRCS Eng (Hon)
Founder and Emeritus Scientific Director NPIMR
Colin Green was one of the pioneers in developing cyclosporine A as a revolutionary new drug to prevent rejection of transplanted organs and helped set up the Restoration of Appearance and Function Trust (RAFT) charity as co-Director of its Institute for Plastic Surgery Research in Mount Vernon Hospital. In 1994 he founded the Northwick Park Institute for Medical Research and remained Director until September 2008. He was made full Professor of Surgical Science at University College London in 1996 and was made the UNESCO Chair in Cryobiology and Academician in the Ukraine National Academy of Sciences in 1998.
His main research interests have been in surgical reconstruction, tissue regeneration, stem cells seeded into decellularised tissues, novel burns treatments and organ transplantation. Most notably, he helped pioneer the development of carbon monoxide releasing molecules as potential therapeutic agents for inflammation, ischaemia-reperfusion damage and bacterial infections, particularly their possible role in coronary artery disease and strokes. He has written more than 500 publications and has a strong interest in global healthcare and education particularly as they impact on conflict resolution and human rights.
Dr Tamir Rashid BSc, MBBS, MRes, PhD, FRCP
Director of Science
Dr Rashid is a Clinical Reader (Associate Professor) and Consultant Hepatologist on part time secondment to the NPIMR.
After graduating in medicine from Imperial College School of Medicine at St Mary’s he completed his clinician-scientist training at the University of Manchester (as an Academic Clinical Fellow) under the supervision of Professor Martin Humphries and then at the University of Cambridge (as a Wellcome Trust Clinical PhD fellow and NIHR Clinical Lecturer) under the supervision of Professors David Lomas and Ludovic Vallier. Following award of an MRC Clinician Scientist Fellowship, he next undertook post-doctoral studies at Stanford (USA) under the mentorship of Professors Hiromitsu Nakauchi and Jeffrey Glenn before returning to King’s College London to establish his first laboratory under the directorship of Professor Fiona Watt. In 2019, Dr Rashid moved back to Imperial.
The research programme led by Dr Rashid focusses on the use of human stem cells for modeling and treating genetic liver diseases. His specific objectives are to generate deeper mechanistic understanding, identify new molecular targets and produced cell & gene based regenerative medicine approaches. These translational ambitions are closely linked to his clinical work in which he runs the NW Thames genetic liver disease service, clinical trials and leads the British Liver Association’s Alpha-1 Antitrypsin specialist interest group.
Over the last 15 years, the impact of Dr Rashid’s work has been recognised through the receipt of numerous international (the American Liver Association Fellow’s Prize) and national (Academy of Medical Sciences UK Young Investigator & British Liver Association Young Investigator) prizes and the creation of two biotech start-ups.